The Staccato system enables rapid onset of action for many drugs.
Simple and Intuitive
The Staccato system is breath actuated, and a patient simply inhales to administer the drug dose.
Fast-Acting, Non-Invasive Treatment
Unlike injections, the Staccato system is noninvasive.
Improved Patient Therapy
Products for the treatment of acute and intermittent conditions.
Unique Therapeutic Effect
Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.
We have already demonstrated that more than 200 FDA-approved compounds are feasible for delivery by the Staccato® system. Currently we have six development programs focused on five acute and intermittent conditions.
As our development pipeline grows and our clinical candidates advance in the development process, we have begun building a commercial infrastructure to support what we hope will be a growing portfolio of approved pharmaceutical products.
